Mettler-Toledo International, Inc. $MTD Shares Purchased by Eventide Asset Management LLC

Eventide Asset Management LLC lifted its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 1.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 50,258 shares of the medical instruments supplier’s stock after purchasing an additional 815 shares during the quarter. Mettler-Toledo International accounts for 1.1% of Eventide Asset Management LLC’s portfolio, making the stock its 21st largest position. Eventide Asset Management LLC’s holdings in Mettler-Toledo International were worth $70,122,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in MTD. Geneos Wealth Management Inc. lifted its holdings in shares of Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after acquiring an additional 30 shares during the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after acquiring an additional 40 shares during the last quarter. Jump Financial LLC lifted its holdings in shares of Mettler-Toledo International by 44.6% in the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after acquiring an additional 125 shares during the last quarter. Cerity Partners LLC lifted its holdings in shares of Mettler-Toledo International by 10.8% in the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after acquiring an additional 392 shares during the last quarter. Finally, AXA S.A. lifted its holdings in shares of Mettler-Toledo International by 2.9% in the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after acquiring an additional 131 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Down 1.0%

Mettler-Toledo International stock opened at $1,129.89 on Friday. The firm has a market cap of $22.84 billion, a PE ratio of 26.50, a price-to-earnings-growth ratio of 2.36 and a beta of 1.27. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The company’s 50 day moving average is $1,203.88 and its two-hundred day moving average is $1,313.71.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The company had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. During the same period in the prior year, the firm posted $8.19 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

MTD has been the topic of several recent analyst reports. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Barclays decreased their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Morgan Stanley reduced their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. Finally, Citigroup reduced their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,408.55.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.